{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:25:41Z","timestamp":1787725541598,"version":"build-2784847793"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2110680"],"award-info":[{"award-number":["W81XWH2110680"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2110711"],"award-info":[{"award-number":["W81XWH2110711"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001625","name":"Foundation to Eradicate Duchenne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["P50HD105328"],"award-info":[{"award-number":["P50HD105328"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Absence of dystrophin protein causes cardiac dysfunction in patients with Duchenne muscular dystrophy (DMD). Unlike boys with DMD, the common mouse model of DMD (B10-\n                    <jats:italic>mdx<\/jats:italic>\n                    ) does not manifest cardiac deficits until late adulthood. This has limited our understanding of the mechanism and therapeutic approaches to target the pediatric onset of cardiac pathology in DMD. Here we show that the\n                    <jats:italic>mdx<\/jats:italic>\n                    mouse model on the DBA\/2\u2009J genetic background (D2-\n                    <jats:italic>mdx<\/jats:italic>\n                    ) displays juvenile-onset cardiac degeneration. Molecular and histological analysis revealed that cardiac damage in this model is linked to increased leukocyte chemotactic signaling and an inability to resolve inflammation. These deficiencies result in chronic inflammation and fibrotic conversion of the extracellular matrix (ECM) in the juvenile D2-\n                    <jats:italic>mdx<\/jats:italic>\n                    heart. To address these pathologies, we tested the utility of pro-resolution therapy to clear chronic cardiac inflammation. Use of an N-formyl peptide receptor (FPR) agonist helped physiologically resolve inflammation and mitigate the downstream events that lead to fibrotic degeneration of cardiomyocytes, preventing juvenile onset cardiac muscle loss. These results establish the utility of D2-\n                    <jats:italic>mdx<\/jats:italic>\n                    model to study events associated with pediatric-onset cardiac damage and demonstrates pro-resolution therapy as an alternate to anti-inflammatory therapy for treating degenerative cardiac pathology that leads to cardiomyopathy in DMD.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-07816-5","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:47:25Z","timestamp":1752137245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Failure to resolve inflammation contributes to juvenile onset cardiac damage in a mouse model of Duchenne muscular dystrophy"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9989-8724","authenticated-orcid":false,"given":"James S.","family":"Novak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Lischin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1950-4164","authenticated-orcid":false,"given":"Prech","family":"Uapinyoying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Hindupur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jae","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajit","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tiufekchiev-Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7776-1954","authenticated-orcid":false,"given":"Davi A. G.","family":"M\u00e1zala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iteoluwakishi H.","family":"Gamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5992-5185","authenticated-orcid":false,"given":"Jyoti K.","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"7816_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Prim. 2021;7:13.","journal-title":"Nat Rev Dis Prim"},{"key":"7816_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919\u201328.","journal-title":"Cell"},{"key":"7816_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","volume":"50","author":"M Koenig","year":"1987","unstructured":"Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987;50:509\u201317.","journal-title":"Cell"},{"key":"7816_CR4","doi-asserted-by":"crossref","unstructured":"Meyers TA, Townsend D. Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy. Int J Mol Sci. 2019,20:4098.","DOI":"10.3390\/ijms20174098"},{"key":"7816_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.semcdb.2016.09.013","volume":"64","author":"AL Serrano","year":"2017","unstructured":"Serrano AL, Munoz-Canoves P. Fibrosis development in early-onset muscular dystrophies: Mechanisms and translational implications. Semin Cell Dev Biol. 2017;64:181\u201390.","journal-title":"Semin Cell Dev Biol"},{"key":"7816_CR6","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1016\/j.biocel.2013.05.001","volume":"45","author":"J Shin","year":"2013","unstructured":"Shin J, Tajrishi MM, Ogura Y, Kumar A. Wasting mechanisms in muscular dystrophy. Int J Biochem Cell Biol. 2013;45:2266\u201379.","journal-title":"Int J Biochem Cell Biol"},{"key":"7816_CR7","doi-asserted-by":"publisher","first-page":"15000","DOI":"10.1073\/pnas.192571199","volume":"99","author":"JN Haslett","year":"2002","unstructured":"Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci USA. 2002;99:15000\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7816_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4330\/wjc.v7.i7.410","volume":"7","author":"S Mavrogeni","year":"2015","unstructured":"Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, Kolovou G. Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol. 2015;7:410\u20134.","journal-title":"World J Cardiol"},{"key":"7816_CR9","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1161\/01.CIR.94.12.3168","volume":"94","author":"P Melacini","year":"1996","unstructured":"Melacini P, Fanin M, Danieli GA, Villanova C, Martinello F, Miorin M, et al. Myocardial involvement is very frequent among patients affected with subclinical Becker\u2019s muscular dystrophy. Circulation. 1996;94:3168\u201375.","journal-title":"Circulation"},{"key":"7816_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000068446","volume":"99","author":"J Finsterer","year":"2003","unstructured":"Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology. 2003;99:1\u201319.","journal-title":"Cardiology"},{"key":"7816_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/mus.21716","volume":"42","author":"C Van Erp","year":"2010","unstructured":"Van Erp C, Loch D, Laws N, Trebbin A, Hoey AJ. Timeline of cardiac dystrophy in 3-18-month-old MDX mice. Muscle Nerve. 2010;42:504\u201313.","journal-title":"Muscle Nerve"},{"key":"7816_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1532-429X-11-40","volume":"11","author":"W Li","year":"2009","unstructured":"Li W, Liu W, Zhong J, Yu X. Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging. J Cardiovasc Magn Reson. 2009;11:40.","journal-title":"J Cardiovasc Magn Reson"},{"key":"7816_CR13","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/cvr\/cvab232","volume":"118","author":"F Canonico","year":"2022","unstructured":"Canonico F, Chirivi M, Maiullari F, Milan M, Rizzi R, Arcudi A, et al. Focus on the road to modelling cardiomyopathy in muscular dystrophy. Cardiovasc Res. 2022;118:1872\u201384.","journal-title":"Cardiovasc Res"},{"key":"7816_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3233\/JND-180324","volume":"5","author":"H Gordish-Dressman","year":"2018","unstructured":"Gordish-Dressman H, Willmann R, Dalle Pazze L, Kreibich A, van Putten M, Heydemann A, et al. Of Mice and Measures\u201d: A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic. J Neuromuscul Dis. 2018;5:407\u201317.","journal-title":"J Neuromuscul Dis"},{"key":"7816_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3233\/JND-221547","volume":"10","author":"A Aartsma-Rus","year":"2023","unstructured":"Aartsma-Rus A, van Putten M, Mantuano P, De Luca A. On the use of D2.B10-Dmdmdx\/J (D2.mdx) Versus C57BL\/10ScSn-Dmdmdx\/J (mdx) Mouse Models for Preclinical Studies on Duchenne Muscular Dystrophy: A Cautionary Note from Members of the TREAT-NMD Advisory Committee on Therapeutics. J Neuromuscul Dis. 2023;10:155\u20138.","journal-title":"J Neuromuscul Dis"},{"key":"7816_CR16","doi-asserted-by":"publisher","first-page":"11805","DOI":"10.3390\/ijms241411805","volume":"24","author":"D De Giorgio","year":"2023","unstructured":"De Giorgio D, Novelli D, Motta F, Cerrato M, Olivari D, Salama A, et al. Characterization of the Cardiac Structure and Function of Conscious D2.B10-Dmd(mdx)\/J (D2-mdx) mice from 16-17 to 24-25 Weeks of Age. Int J Mol Sci. 2023;24:11805.","journal-title":"Int J Mol Sci"},{"key":"7816_CR17","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1172\/JCI39845","volume":"119","author":"A Heydemann","year":"2009","unstructured":"Heydemann A, Ceco E, Lim JE, Hadhazy M, Ryder P, Moran JL, et al. Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice. J Clin Invest. 2009;119:3703\u201312.","journal-title":"J Clin Invest"},{"key":"7816_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.23819","volume":"73","author":"KM Flanigan","year":"2013","unstructured":"Flanigan KM, Ceco E, Lamar KM, Kaminoh Y, Dunn DM, Mendell JR, et al. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol. 2013;73:481\u20138.","journal-title":"Ann Neurol"},{"key":"7816_CR19","doi-asserted-by":"crossref","unstructured":"Tandon A, Villa CR, Hor KN, Jefferies JL, Gao Z, Towbin JA, et al. Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy. J Am Heart Assoc. 2015;4:e001338.","DOI":"10.1161\/JAHA.114.001338"},{"key":"7816_CR20","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jacc.2012.12.008","volume":"61","author":"G Schram","year":"2013","unstructured":"Schram G, Fournier A, Leduc H, Dahdah N, Therien J, Vanasse M, et al. All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol. 2013;61:948\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"7816_CR21","doi-asserted-by":"crossref","unstructured":"Bourke J, Turner C, Bradlow W, Chikermane A, Coats C, Fenton M, et al. Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations. Open Heart. 2022;9:e001977.","DOI":"10.1136\/openhrt-2022-001977"},{"key":"7816_CR22","doi-asserted-by":"publisher","first-page":"e88360","DOI":"10.1371\/journal.pone.0088360","volume":"9","author":"PM Janssen","year":"2014","unstructured":"Janssen PM, Murray JD, Schill KE, Rastogi N, Schultz EJ, Tran T, et al. Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy. PLoS One. 2014;9:e88360.","journal-title":"PLoS One"},{"key":"7816_CR23","doi-asserted-by":"publisher","first-page":"e201800186","DOI":"10.26508\/lsa.201800186","volume":"2","author":"CR Heier","year":"2019","unstructured":"Heier CR, Yu Q, Fiorillo AA, Tully CB, Tucker A, Mazala DA, et al. Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy. Life Sci Alliance. 2019;2:e201800186.","journal-title":"Life Sci Alliance"},{"key":"7816_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12872-017-0627-x","volume":"17","author":"S Mavrogeni","year":"2017","unstructured":"Mavrogeni S, Giannakopoulou A, Papavasiliou A, Markousis-Mavrogenis G, Pons R, Karanasios E, et al. Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with\/without perindopril. BMC Cardiovasc Disord. 2017;17:197.","journal-title":"BMC Cardiovasc Disord"},{"key":"7816_CR25","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1001\/jama.2022.4315","volume":"327","author":"M Guglieri","year":"2022","unstructured":"Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, et al. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial. JAMA. 2022;327:1456\u201368.","journal-title":"JAMA"},{"key":"7816_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/mus.27490","volume":"66","author":"RJ Butterfield","year":"2022","unstructured":"Butterfield RJ, Kirkov S, Conway KM, Johnson N, Matthews D, Phan H, et al. Evaluation of effects of continued corticosteroid treatment on cardiac and pulmonary function in non-ambulatory males with Duchenne muscular dystrophy from MD STARnet. Muscle Nerve. 2022;66:15\u201323.","journal-title":"Muscle Nerve"},{"key":"7816_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev-pharmtox-051821-042743","volume":"63","author":"M Perretti","year":"2023","unstructured":"Perretti M, Dalli J. Resolution Pharmacology: Focus on Pro-Resolving Annexin A1 and Lipid Mediators for Therapeutic Innovation in Inflammation. Annu Rev Pharm Toxicol. 2023;63:449\u201369.","journal-title":"Annu Rev Pharm Toxicol"},{"key":"7816_CR28","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.3390\/cells10123524","volume":"10","author":"A Sinniah","year":"2021","unstructured":"Sinniah A, Yazid S, Flower RJ. From NSAIDs to Glucocorticoids and Beyond. Cells. 2021;10:3524.","journal-title":"Cells"},{"key":"7816_CR29","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1515\/hsz-2016-0200","volume":"397","author":"T Gobbetti","year":"2016","unstructured":"Gobbetti T, Cooray SN. Annexin A1 and resolution of inflammation: tissue repairing properties and signalling signature. Biol Chem. 2016;397:981\u201393.","journal-title":"Biol Chem"},{"key":"7816_CR30","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1172\/JCI124635","volume":"130","author":"S McArthur","year":"2020","unstructured":"McArthur S, Juban G, Gobbetti T, Desgeorges T, Theret M, Gondin J, et al. Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation. J Clin Invest. 2020;130:1156\u201367.","journal-title":"J Clin Invest"},{"key":"7816_CR31","doi-asserted-by":"publisher","first-page":"18246","DOI":"10.1038\/srep18246","volume":"5","author":"E Leikina","year":"2015","unstructured":"Leikina E, Defour A, Melikov K, Van der Meulen JH, Nagaraju K, Bhuvanendran S, et al. Annexin A1 Deficiency does not Affect Myofiber Repair but Delays Regeneration of Injured Muscles. Sci Rep. 2015;5:18246.","journal-title":"Sci Rep."},{"key":"7816_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/bjp.2008.252","volume":"155","author":"F D\u2019Acquisto","year":"2008","unstructured":"D\u2019Acquisto F, Perretti M, Flower RJ. Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharm. 2008;155:152\u201369.","journal-title":"Br J Pharm"},{"key":"7816_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molmet.2019.10.008","volume":"31","author":"B Tourki","year":"2020","unstructured":"Tourki B, Kain V, Pullen AB, Norris PC, Patel N, Arora P, et al. Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure. Mol Metab. 2020;31:138\u201349.","journal-title":"Mol Metab"},{"key":"7816_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1476-5381.2012.02176.x","volume":"168","author":"C Qin","year":"2013","unstructured":"Qin C, Buxton KD, Pepe S, Cao AH, Venardos K, Love JE, et al. Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26). Br J Pharm. 2013;168:238\u201352.","journal-title":"Br J Pharm"},{"key":"7816_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2015.04.003","volume":"84","author":"V Kain","year":"2015","unstructured":"Kain V, Ingle KA, Colas RA, Dalli J, Prabhu SD, Serhan CN, et al. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. J Mol Cell Cardiol. 2015;84:24\u201335.","journal-title":"J Mol Cell Cardiol"},{"key":"7816_CR36","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1038\/s41598-017-10441-8","volume":"7","author":"V Kain","year":"2017","unstructured":"Kain V, Liu F, Kozlovskaya V, Ingle KA, Bolisetty S, Agarwal A, et al. Resolution Agonist 15-epi-Lipoxin A(4) Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing. Sci Rep. 2017;7:9999.","journal-title":"Sci Rep."},{"key":"7816_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jacbts.2021.07.007","volume":"6","author":"RA Garcia","year":"2021","unstructured":"Garcia RA, Lupisella JA, Ito BR, Hsu MY, Fernando G, Carson NL, et al. Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction. JACC Basic Transl Sci. 2021;6:676\u201389.","journal-title":"JACC Basic Transl Sci"},{"key":"7816_CR38","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1021\/acsptsci.2c00042","volume":"5","author":"J Lupisella","year":"2022","unstructured":"Lupisella J, St-Onge S, Carrier M, Cook EM, Wang T, Sum C, et al. Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial Infarction. ACS Pharm Transl Sci. 2022;5:892\u2013906.","journal-title":"ACS Pharm Transl Sci"},{"key":"7816_CR39","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","volume":"81","author":"G Bulfield","year":"1984","unstructured":"Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA. 1984;81:1189\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7816_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"7816_CR41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 2011;12:323.","journal-title":"BMC Bioinforma"},{"key":"7816_CR42","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 2015;4:1521.","journal-title":"F1000Res"},{"key":"7816_CR43","doi-asserted-by":"publisher","first-page":"e135703","DOI":"10.1172\/jci.insight.135703","volume":"5","author":"DA Mazala","year":"2020","unstructured":"Mazala DA, Novak JS, Hogarth MW, Nearing M, Adusumalli P, Tully CB, et al. TGF-beta-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model. JCI Insight. 2020;5:e135703.","journal-title":"JCI Insight"},{"key":"7816_CR44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41420-023-01503-0","volume":"9","author":"DAG Mazala","year":"2023","unstructured":"Mazala DAG, Hindupur R, Moon YJ, Shaikh F, Gamu IH, Alladi D, et al. Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD. Cell Death Discov. 2023;9:224.","journal-title":"Cell Death Discov"},{"key":"7816_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.omtm.2017.06.006","volume":"6","author":"CH Hakim","year":"2017","unstructured":"Hakim CH, Wasala NB, Pan X, Kodippili K, Yue Y, Zhang K, et al. A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA\/2J-mdx Model of Duchenne Muscular Dystrophy. Mol Ther Methods Clin Dev. 2017;6:216\u201330.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"7816_CR46","first-page":"100012","volume":"1","author":"CC Hart","year":"2022","unstructured":"Hart CC, Lee YI, Hammers DW, Sweeney HL. Evaluation of the DBA\/2J mouse as a potential background strain for genetic models of cardiomyopathy. J Mol Cell Cardiol. 2022;1:100012.","journal-title":"J Mol Cell Cardiol"},{"key":"7816_CR47","doi-asserted-by":"publisher","first-page":"818662","DOI":"10.3389\/fcvm.2022.818662","volume":"9","author":"Y Kayashima","year":"2022","unstructured":"Kayashima Y, Clanton CA, Lewis AM, Sun X, Hiller S, Huynh P, et al. Reduction of Stabilin-2 Contributes to a Protection Against Atherosclerosis. Front Cardiovasc Med. 2022;9:818662.","journal-title":"Front Cardiovasc Med"},{"key":"7816_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mod.2014.12.001","volume":"135","author":"D Nishimura","year":"2015","unstructured":"Nishimura D, Sakai H, Sato T, Sato F, Nishimura S, Toyama-Sorimachi N, et al. Roles of ADAM8 in elimination of injured muscle fibers prior to skeletal muscle regeneration. Mech Dev. 2015;135:58\u201367.","journal-title":"Mech Dev"},{"key":"7816_CR49","first-page":"249","volume":"49","author":"M Wang","year":"2019","unstructured":"Wang M, Gao X, Zhao K, Chen H, Xu M, Wang K. Effect of TREM2 on Release of Inflammatory Factor from LPS-stimulated Microglia and Its Possible Mechanism. Ann Clin Lab Sci. 2019;49:249\u201356.","journal-title":"Ann Clin Lab Sci"},{"key":"7816_CR50","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/hmg\/ddn376","volume":"18","author":"SA Villalta","year":"2009","unstructured":"Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Human Mol Genet. 2009;18:482\u201396.","journal-title":"Human Mol Genet"},{"key":"7816_CR51","doi-asserted-by":"publisher","first-page":"eadd9984","DOI":"10.1126\/sciadv.add9984","volume":"9","author":"G Coulis","year":"2023","unstructured":"Coulis G, Jaime D, Guerrero-Juarez C, Kastenschmidt JM, Farahat PK, Nguyen Q, et al. Single-cell and spatial transcriptomics identify a macrophage population associated with skeletal muscle fibrosis. Sci Adv. 2023;9:eadd9984.","journal-title":"Sci Adv"},{"key":"7816_CR52","doi-asserted-by":"publisher","first-page":"106982","DOI":"10.1016\/j.phrs.2023.106982","volume":"197","author":"S Sanchez-Garcia","year":"2023","unstructured":"Sanchez-Garcia S, Jaen RI, Fernandez-Velasco M, Delgado C, Bosca L, Prieto P. Lipoxin-mediated signaling: ALX\/FPR2 interaction and beyond. Pharmacol Res. 2023;197:106982.","journal-title":"Pharmacol Res"},{"key":"7816_CR53","doi-asserted-by":"publisher","first-page":"106634","DOI":"10.1016\/j.prostaglandins.2022.106634","volume":"160","author":"M Yang","year":"2022","unstructured":"Yang M, Song XQ, Han M, Liu H. The role of Resolvin D1 in liver diseases. Prostaglandins Other Lipid Mediat. 2022;160:106634.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"7816_CR54","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1111\/bph.15212","volume":"177","author":"M Perretti","year":"2020","unstructured":"Perretti M, Godson C. Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology. Br J Pharm. 2020;177:4595\u20134600.","journal-title":"Br J Pharm"},{"key":"7816_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bcp.2016.04.014","volume":"114","author":"C Dahlgren","year":"2016","unstructured":"Dahlgren C, Gabl M, Holdfeldt A, Winther M, Forsman H. Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria. Biochem Pharm. 2016;114:22\u201339.","journal-title":"Biochem Pharm"},{"key":"7816_CR56","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.4049\/jimmunol.164.4.1663","volume":"164","author":"C Godson","year":"2000","unstructured":"Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol. 2000;164:1663\u20137.","journal-title":"J Immunol"},{"key":"7816_CR57","doi-asserted-by":"publisher","first-page":"275ra220","DOI":"10.1126\/scitranslmed.aaa1065","volume":"7","author":"G Fredman","year":"2015","unstructured":"Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, et al. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med. 2015;7:275ra220.","journal-title":"Sci Transl Med"},{"key":"7816_CR58","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.4049\/jimmunol.178.7.4595","volume":"178","author":"M Scannell","year":"2007","unstructured":"Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, Godson C, et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol. 2007;178:4595\u2013605.","journal-title":"J Immunol"},{"key":"7816_CR59","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1172\/JCI37662","volume":"119","author":"SA Vetrone","year":"2009","unstructured":"Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, et al. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-b. eta J Clin Invest. 2009;119:1583\u201394.","journal-title":"eta J Clin Invest"},{"key":"7816_CR60","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1093\/hmg\/ddz181","volume":"28","author":"I Kramerova","year":"2019","unstructured":"Kramerova I, Kumagai-Cresse C, Ermolova N, Mokhonova E, Marinov M, Capote J, et al. Spp1 (osteopontin) promotes TGFbeta processing in fibroblasts of dystrophin-deficient muscles through matrix metalloproteinases. Human Mol Genet. 2019;28:3431\u201342.","journal-title":"Human Mol Genet"},{"key":"7816_CR61","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1073\/pnas.93.9.3942","volume":"93","author":"JM Shipley","year":"1996","unstructured":"Shipley JM, Wesselschmidt RL, Kobayashi DK, Ley TJ, Shapiro SD. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci USA. 1996;93:3942\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7816_CR62","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1172\/JCI72181","volume":"124","author":"AB Aurora","year":"2014","unstructured":"Aurora AB, Porrello ER, Tan W, Mahmoud AI, Hill JA, Bassel-Duby R, et al. Macrophages are required for neonatal heart regeneration. J Clin Invest. 2014;124:1382\u201392.","journal-title":"J Clin Invest"},{"key":"7816_CR63","doi-asserted-by":"publisher","first-page":"16029","DOI":"10.1073\/pnas.1406508111","volume":"111","author":"KJ Lavine","year":"2014","unstructured":"Lavine KJ, Epelman S, Uchida K, Weber KJ, Nichols CG, Schilling JD, et al. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc Natl Acad Sci USA. 2014;111:16029\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7816_CR64","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","volume":"110","author":"NG Frangogiannis","year":"2012","unstructured":"Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110:159\u201373.","journal-title":"Circ Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07816-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07816-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07816-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:30:58Z","timestamp":1757223058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07816-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7816"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07816-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.15.607998","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JKJ and JSN have filed a provisional intellectual property application related to the findings reported in this manuscript. The authors have no other active or potential competing or financial interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal procedures were conducted following guidelines for the care and use of laboratory animals as approved by the Institutional Animal Care and Use Committee (IACUC) of Children\u2019s National Research Institute (CNRI). The animal care facility at CNRI meets Federal (USDA Registration Number 10-R-0003) for animal care and is accredited by the American Association for Accreditation of Laboratory Animal Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"505"}}